PROphylaxis for paTiEnts at Risk of COVID-19 infecTion

NCT04389359 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Regulatory approvals not received

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine Sulfate 200 MG

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]